Background: Among human host factors known to modulate HIV disease progression, the C-type lectins, dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin, DC-SIGN and the liver/lymph node-specific L-SIGN have been poorly described in children with HIV. We aimed to study the exon 4 repeat-region polymorphisms, and assess the impact of DC/L-SIGN homozygous and heterozygous genotypes among pediatric slow and rapid progressors.
Background: Uganda like most countries is providing Option B+ to HIV+ mothers. However, patients who start ART with a high immunity are often thought to be poorly retained in care (Tayler et al, 2010) . Poor retention in care predicts poorer survival with HIV infection (Thomas et al, 2007) . Patients with CD4 >350 cells/L are asymptomatic and presumed to be comfortable with their status quo. The study hypothesized that CD4 <350 cell/l at initiation of Option B+ would also predict higher retention compared to CD4 >350 cell/l.
Methods & Materials:
A retrospective cohort study was done on mothers that were initiated on Option B+ between December 2012 and January 2013 in six urban public health facilities in Uganda. Patients were observed starting at Option B+ initiation to patient outcome such as at death, transfer out, loss to follow-up and 12 months after initiation. Only mothers whose CD4 was recorded at initiation of Option B+ were considered for analysis.
Results: A total of 601 mothers with mean age 25.0 years (95% CI: 21-28) were enrolled and of these 65% were still in care one year after option B+ initiation. At the time of enrollment, 313 mothers had CD4 > 350, 74 had CD4 <350 while 212 had no CD4 done. Majority, (80%) mothers had no prior exposure to ARVs at the time of initiation. There was a significant relationship between retention and prior treatment, age of mother > 20yrs, and CD4 levels. After regression modelling, the odds of being in care among CD4 >350 were 2.21 (p=005) times more likely to stay in care compared to those with lower CD4. There was no significant relationship between retention and age or prior ART.
Conclusion: Contrary to the study hypothesis and knowledge among the general HIV patients, our study revealed that women started on option B+ with CD4 >350 cell/ul were 2.21 times more likely to stay in care, one year after ART initiation. http://dx.doi.org/10.1016/j.ijid.2016.02.599
